A Randomized, Double-Blind, Placebo Controlled Exploratory Study of Augmentation of Seroquel XR With Pramipexole Dihydrochloride for Bipolar Depression
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2013
At a glance
- Drugs Pramipexole (Primary) ; Quetiapine (Primary)
- Indications Bipolar depression
- Focus Therapeutic Use
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 May 2012 Planned end date changed from 1 Jan 2011 to 1 Nov 2012 as reported by ClinicalTrials.gov.
- 31 May 2012 Additional trial location (USA) added as reported by ClinicalTrials.gov.